Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD44 (clone DB1G0Z5L). We employs the Retrovirus (CMV-GFP-GR-EcoRI) vector components and the SynExpress system of the Exons RNA Editing/Positive feedback for a robust and sustained response against cancers.
Host
Mouse
Target
CD44
Clone
DB1G0Z5L
Species Reactivity
Human; Non-Human Primate
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
CMV
Effector Gene
GR
Insertion Sites
EcoRI
Gene Modification
RNA Editing
Modification Domain
Exons
Carrier Type
Retrovirus
Transformation Accuracy
0.86
Cell Culture
Adherent Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.